Recent News

• 09.05.2025 - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.05.2025 - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.05.2025 - Q2 2025 Pacira BioSciences, Inc. Earnings Conference Call
• 08.05.2025 - Pacira BioSciences Reports Second Quarter 2025 Financial Results
• 08.05.2025 - Pacira BioSciences Reports Second Quarter 2025 Financial Results
• 07.24.2025 - Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025
• 07.24.2025 - Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025
• 07.22.2025 - Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts
• 07.22.2025 - Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts

Recent Filings

• 09.04.2025 - 144 Report of proposed sale of securities
• 08.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.08.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 08.07.2025 - 144 Report of proposed sale of securities
• 08.05.2025 - 8-K Current report
• 08.05.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - EX-99.1 EX-99.1
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities